Category: Patent Litigation
-
Munich LD gives textbook example of how to address venue competence in UPC disputes involving multiple defendants
For the second panel of the Unified Patent Court’s Munich Local Divison, Judge-rapporteur Dr. Daniel Voß (“Voss”) has rejected a venue-related preliminary objection.
-
Samsung brings FRAND claim against ZTE in 4th jurisdiction: counterclaim in Unified Patent Court’s Mannheim Local Division
After bringing standalone FRAND/SEP actions in the UK, Germany and the United States, Samsung has now also brought a FRAND counterclaim in the UPC.
-
UPC’s Hamburg LD enters Unitary Patent PI: defendant bears burden on invalidity; new market opportunity is irreparable harm; security not automatic
A new decision by the UPC’s Hamburg LD lays out standards that create opportunities for other patentees seeking preliminary injunctions.
-
Patent-related complaints continue to dominate USITC Section 337 investigations
While the total number of Section 337 investigations dropped slightly in 2024, patent-related complaints continue to make up 88% of such ITC cases.
-
European Patent Office aligns with Unified Patent Court on claim construction standard: Enlarged Board of Appeal decision
Today’s decision by a Board of Appeal of the European Patent Office lays out a claim construction standard that is materially consistent with that of the Unified Patent Court’s Court of Appeal.
-
U.S. judge deprioritizes Samsung’s FRAND case against ZTE, UK judge requested post-hearing briefing on cross-jurisdictional implications
A federal judge in California has pushed back a hearing date by almost four months and a UK judge requested post-hearing briefing on Samsung’s multi-country FRAND lawsuits.
-
Federal Circuit decision in Optis v. Apple SEP case shows why UK courts should leave other jurisdictions alone: misconception exposed
In the seemingly neverending SEP story between Optis and Apple, the Federal Circuit has ordered a U.S. retrial on the merits and what would be a third damages trial in the same case.
-
Novartis and MSN settle part of chronic heart failure patent fight, but key patent remains
Novartis and MSN have settled one prong of their U.S. Entresto patent infringement dispute in the Federal Circuit, but the companies will continue to litigate over a second patent as Novartis strives to defend its corner of the chronic heart failure drug market.
-
UPC Dusseldorf LD affirms 10x v. Curio preliminary injunction in final ruling, creates opening for late claim construction arguments
Having recently settled its dispute with Bruker (NanoString) on presumably favorable terms, 10x is now continuing its patent enforcement with a victory over Curio.
-
Microsoft seeks declaratory judgment against Biogy over RFC one-time passcode patent in Northern District of California
Microsoft has alleged that Biogy’s prior “litigation behavior” confirms it will be its next target in an RFC patent infringement suit.